Volume 40, Issue 2 pp. 99-103

Gamma-knife radiosurgery in pediatric cerebral and skull base tumors

Asle Hirth MD

Corresponding Author

Asle Hirth MD

Department of Pediatrics, Haukeland University Hospital, Bergen, Norway

Department of Pediatrics, Haukeland University Hospital, 5020 Bergen, Norway.Search for more papers by this author
Paal-Henning Pedersen MD, PhD

Paal-Henning Pedersen MD, PhD

Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway

Search for more papers by this author
Roald Baardsen MD

Roald Baardsen MD

Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway

Search for more papers by this author
John Ludvig Larsen MD, PhD

John Ludvig Larsen MD, PhD

Department of Radiology, Haukeland University Hospital, Bergen, Norway

John Ludvig Larsen is a Professor.

Search for more papers by this author
Bård K. Krossnes MD

Bård K. Krossnes MD

Department of Pathology, Haukeland University Hospital, Bergen, Norway

Search for more papers by this author
Jon Helgestad MD, PhD

Jon Helgestad MD, PhD

Department of Pediatrics, Haukeland University Hospital, Bergen, Norway

Search for more papers by this author
First published: 29 November 2002
Citations: 9

Abstract

Background

This retrospective study of 12 children with cerebral or skull base tumors was undertaken to evaluate morbidity and outcome after gamma-knife surgery.

Procedure

Twelve consecutive children treated with stereotactic radiosurgery in a curative intent were reviewed. There were five girls and seven boys. The mean age at diagnosis was 5.8 years and at radiosurgical treatment 8.4 years. There were four pilocytic astrocytomas, two craniopharyngeomas, two pineoblastomas, two ependymomas, and two other tumors of high malignancy. We used a 201-source Co60 Leksell gamma knife and all children were treated in general anesthesia.

Results

The mean tumor volume was 3.7 cm3 and the mean tumor margin dose was 13.8 Gy. Seven patients remained stable after gamma-knife treatment with a mean follow- up of 78.6 months. One patient died during follow-up. The remaining four patients had progressive disease, two within and two outside the irradiated field, and have received further treatment. They are still alive with and without disease with a mean follow-up of 96.8 months.

Conclusion

Gamma-knife surgery is an effective treatment in some non-resectable cerebral and skull base pediatric tumors. In most cases, it is used in combination with other therapeutic modalities. It is safe and well tolerated. Med Pediatr Oncol 2003;40:99–103. © 2003 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.